[
    [
        {
            "time": "",
            "original_text": "美迪西要来科创板了，它会成为下一个药明康德吗？",
            "features": {
                "keywords": [
                    "美迪西",
                    "科创板",
                    "药明康德"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "医疗服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "美迪西要来科创板了，它会成为下一个药明康德吗？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "香港领先的私家屈光治疗服务商清晰医疗向港交所递表，药明康德持股20%，已成为香港领先屈光治疗企业",
            "features": {
                "keywords": [
                    "清晰医疗",
                    "港交所",
                    "药明康德",
                    "屈光治疗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗服务",
                    "眼科治疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "香港领先的私家屈光治疗服务商清晰医疗向港交所递表，药明康德持股20%，已成为香港领先屈光治疗企业",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]